Yellow header pointerDosing

TECVAYLI® is a ready-to-use treatment and is given:

By a doctor or nurse as a monotherapy, which means it is not administered in combination with other relapsed or refractory multiple myeloma (RRMM) therapies.

As a under the skin, usually in your stomach area (abdomen), your thigh, or another area of your body.

A family having lemonade in the backyard
TECVAYLI® starts with “step-up” dosing

Step-up dosing is done to reduce the chance of getting Cytokine Release Syndrome (CRS) and/or experiencing neurologic problems by slowly initiating TECVAYLI® starting with a lower dose.

Before each step-up dose and your first treatment dose, you will receive medicines to help reduce your risk and/or lessen the severity of a serious or life-threatening side effect known as CRS

You should be hospitalized for 48 hours after each dose in the step-up dosing schedule

The amount of TECVAYLI® you receive will be based on your body weight

TECVAYLI® (teclistamab-cqyv) step-up dosing scheduleTECVAYLI® (teclistamab-cqyv) step-up dosing schedule

Step-up dose 2 and/or the first treatment dose may be given between 2 to 4 days after the previous step-up dose.

Your healthcare provider will decide the number of days to wait between your doses of TECVAYLI® and how many treatments you will receive. Your schedule may change so your healthcare team can manage any side effects.

Continued treatment will be weekly dosing and may switch to dosing every 2 weeks for
certain patients

After step-up dosing, TECVAYLI® is given weekly. If your healthcare provider determines you are responding (a complete response or better) and continue to respond for at least 6 months, you may be able to receive your treatment once every 2 weeks.

TECVAYLI® (teclistamab-cqyv) ongoing dosing scheduleTECVAYLI® (teclistamab-cqyv) ongoing dosing schedule

Your healthcare provider will determine if and when your dosing schedule changes based on how you are responding and how long you will receive treatment. After your step-up doses, your healthcare provider will
also decide if you need to receive medicines to help reduce your risk of CRS with future doses.

Tell your doctor or healthcare provider about any medications you are currently taking, including prescription medicines, over-the-counter medicines, vitamins, and herbal supplements.

The most prescribed bispecific antibody for the treatment of relapsed or refractory multiple myeloma (RRMM)*

*According to ordering data from IQVIA.

 

Once you and your doctor have decided that TECVAYLI® is right for you, sign up for TECVAYLI withMe

TECVAYLI withMe: personalized 1-on-1 support, logo

TECVAYLI withMe: Personalized 1-on-1 Support

You have access to free, dedicated support. Your Care Navigator is here to help guide you to support solutions throughout your treatment journey, so you feel informed and empowered.

Starting a new treatment can be overwhelming and you may still have questions. We are here to help.

  • Free 1-on-1 Dedicated Care Navigator Support

  • Cost Support Options Regardless of Your Insurance Type

  • Additional Resources and Community Connections

OR

The support and resources provided by TECVAYLI withMe are not intended to provide medical advice, replace a treatment plan you receive from your doctor or nurse, or serve as a reason for you to start or stay on treatment.